Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer

By sjmartinez • February 26, 2024

Edwards DM, Sankar K, Alseri A, Jiang R, Schipper M, Miller S, Dess K, Strohbehn GW, Elliott DA, Moghanaki D, Ramnath N, Green MD, Bryant AK. Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):963-970. doi: 10.1016/j.ijrobp.2023.09.050. Epub 2023 Oct 2. PMID: 37793573.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Latency of Hypertensive Disorders of Pregnancy and Cardiovascular Risk 2-7 Years After Delivery

Shree S, Pike M, Yee LM, Levine L, Simhan H, Silver RM, Greenland P, Saade G, Bairey Merz CN, Chung J, Cleary EM, Grobman W,[...]

Vessel-density distribution mapping on portal venous CT and deep learning for 2-year overall survival risk stratification after transarterial chemoembolization in hepatocellular carcinoma

Wang C, He Y, Wang Y, Deng Z, Wang L, Li D. Vessel-density distribution mapping on portal venous CT and deep learning for 2-year overall[...]

AI-Derived LA Volume Index, LA/RA and LA/LV Volume Ratios From Coronary Artery Calcium Scans Predict Long-Term Atrial Fibrillation and Stroke

Azimi A, Atlas K, Reeves AP, Zhang C, Wasserthal J, Mirjalili SR, Mozafarybazargany M, Hashemi A, Atlas T, Henschke CI, Yankelevitz DF, Zulueta JJ, Branch[...]